Article Information
History
- June 22, 2022.
Article Versions
- Version 1 (June 21, 2022 - 16:52).
- You are currently viewing Version 2 of this article (June 22, 2022 - 21:31).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Joseph Blayney1,
- Helena Francis1,
- Brendan Camellato2,
- Leslie Mitchell2,
- Rosa Stolper1,
- Jef Boeke2,3,
- Douglas Higgs1 and
- Mira Kassouf1,*
- 1Weatherall Institute of Molecular Medicine, University of Oxford, The John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK
- 2Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY 10016
- 3Department of Biomedical Engineering, NYU Tandon School of Engineering, Brooklyn NY 11201
- ↵* Corresponding author; email: mira.kassouf{at}imm.ox.ac.uk
Posted June 22, 2022.
Super-enhancers require a combination of classical enhancers and novel facilitator elements to drive high levels of gene expression
